Keurig Dr Pepper Inc. (KDP) Stock Price & How to Invest

Keurig Dr Pepper was created by the 2018 combination of Keurig Green Mountain and Dr Pepper Snapple, and it sells two quite different things. One is American liquid refreshment beverages: Dr Pepper, Canada Dry, 7UP, A&W, Sunkist, Snapple, Core hydration and the Ghost energy brand, sold through a mix of owned distribution and third-party bottlers. The other is coffee: Keurig brewers, K-Cup pods and, since the tender offer closed on April 1, 2026, the global portfolio of JDE Peet's, which brings Jacobs, L'OR, Douwe Egberts, Tassimo, Senseo and the Peet's brand across more than 100 markets. The company now reports four segments (U.S. Refreshment Beverages, U.S. Coffee, KDP International and JDE Peet's) and posted second-quarter 2026 net sales of ~$7.31 billion, of which ~$2.80 billion came from the newly acquired coffee business.

The investment picture is unusually split for a consumer staples name. Beverages are working: U.S. Refreshment Beverages grew net sales ~10% in the second quarter at a ~29.3% operating margin, led by energy and sports hydration. Coffee is not: U.S. Coffee net sales fell ~3.2% with coffee volumes down ~12.8%, and segment operating income dropped ~36%, squeezed by green coffee costs, tariffs and pods that consumers are buying less often. Paying ~EUR 15.1 billion (~$17.4 billion) in cash for JDE Peet's left roughly ~$32 billion of net debt, pro forma leverage of ~4.4x, $4.5 billion of 4.75% convertible preferred stock held by KKR and Apollo, and a 49% outside stake in the pod manufacturing joint venture. Management intends to resolve this by separating the coffee portfolio into its own US-listed company through a tax-free spin-off in early 2027, which is the event most holders are underwriting. Reported GAAP earnings are close to meaningless in the meantime, so the argument turns on adjusted profitability, synergy capture and whether coffee volumes stabilise before the split.

Leverage is the dominant risk: total debt of ~$33.5 billion against ~$1.5 billion of cash, with net interest expense up ~88% year over year in the first half. The capital structure now has claimants ahead of common holders, including $4.5 billion of convertible preferred paying 4.75% (convertible at $37.25, subject to adjustment on separation) and a 49% partner in the pod manufacturing joint venture targeted at a 6.375% internal rate of return on its $4 billion during the first five years. U.S. coffee volumes fell ~12.8% in the quarter on price elasticity and single serve category softness, and the company flags green coffee, Arabica and Robusta, as a volatile input it cannot always fix by contract. The long-running single-serve antitrust multidistrict litigation in the Southern District of New York continues, with remaining plaintiffs collectively claiming more than $1.5 billion in damages (class certification for direct purchasers was denied in October 2025, summary judgment is fully briefed, and new individual suits were filed in 2026); KDP has accrued nothing for it. Finally, the separation itself is conditional, and goodwill and intangibles of ~$67.9 billion now represent roughly 77% of total assets, which is where any impairment would land if the coffee turnaround disappoints.

17 analysts publish price targets on KDP, averaging $35.88 against a $31.44 price as of August 2026, or +14.1%. The published targets run from $29.00 to $42.00, a moderate spread, and the ratings split 12 buy, 6 hold, 0 sell. Over the last six months there have been 9 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full KDP forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Keurig Dr Pepper Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. A tax-free spin-off targeted for early 2027. KDP announced on August 25, 2025 that it intends to separate its beverage and coffee portfolios into two independent, publicly traded companies, and the 10-Q describes the mechanism as a tax-free spin-off of the coffee business. The most optimistic published target, $42.00, assumes this works close to its best case.

The case against. Leverage is the dominant risk: total debt of ~$33.5 billion against ~$1.5 billion of cash, with net interest expense up ~88% year over year in the first half. The most pessimistic target, $29.00, is roughly what KDP is worth if this bites instead.

Read the full bull and bear case on KDP, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Keurig Dr Pepper Inc.'s investor relations page or your broker.

• Market cap: ~$42.8B
• Revenue (TTM): ~$20.1B
• 2026 net sales guidance: ~$25.9B to ~$26.4B
• Adjusted operating margin (Q2 2026): ~20.2%
• Forward P/E: ~13x (vs ~32x trailing GAAP)
• Net debt / pro forma leverage: ~$32B / ~4.4x

The gap between a ~13x forward multiple and a ~32x trailing GAAP multiple is entirely an artifact of the acquisition: a ~$314 million inventory step-up ran through cost of sales in the quarter, $134 million of accelerated JDE Peet's stock compensation hit SG&A, and preferred dividends now reduce income attributable to common holders. Adjusted diluted EPS of ~$0.57 in the second quarter rose ~16.3% while GAAP diluted EPS fell to ~$0.04. Shares changed hands near ~$31 in mid-August 2026 with a dividend yield of roughly ~2.9%, which is where the valuation debate sits: a staples multiple applied to a company whose reported numbers will not be comparable to anything until after the split.

If you want KDP exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to KDP: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get KDP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (TCAF), which spreads the position across many companies. Or build it into a focused thematic portfolio, so KDP sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where KDP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

KDP is a defensive-looking staples name in the middle of the least defensive year of its life, priced near 13 times forward earnings while it merges one business and prepares to spin off another.

Whether KDP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is KDP a buy or a sell?, and where the stock could go from here in the KDP stock forecast.

For income investors, whether KDP pays a dividend and how the payout looks is covered in does KDP pay a dividend? And to weigh KDP against a peer, read the full side-by-side comparisons: KDP vs KO and KDP vs PEP.